Schizophrenia is a chronic and debilitating mental illness that affects about 1 percent of the population worldwide, casting a long shadow over the lives of individuals and their families. It’s a ...
Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity in brain tissue from people ...
Neurodiversity could be broadly thought of as a celebration of the many ways of thinking, feeling, and interacting with the world. Neurodivergent individuals are those whose brains process information ...
Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better understanding of these conditions and paving the way toward targeted treatment. Like ...
Schizophrenia is occasionally associated with a higher risk of aggressive behavior, but the physical brain differences linked ...
Schizoaffective disorder and schizophrenia have several symptoms in common, like hallucinations, delusions, and disorganized thinking or behavior. But although these conditions may resemble each other ...
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results